Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective
英国视角下的肉毒杆菌毒素A(BOTOX®)治疗成人神经源性逼尿肌过度活动症尿失禁的成本效益分析
期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-014-0245-8
Hamid, Rizwan; Loveman, Clara; Millen, Jim; Globe, Denise; Corbell, Catherine; Colayco, Danielle; Stanisic, Sanja; Gultyaev, Dmitry